- 2026-09-14 BrokersView has found that Ambrielle Novairex is an unregulated broker
Ambrielle Novairex’s website provides no regulatory disclosures and fails to list basic corporate information, such as its legal entity name, registered address, jurisdiction of incorporation, or contact details. This lack of transparency makes it impossible to verify whether the platform holds any valid license or operates under legitimate oversight.
Platforms with these characteristics are often unregulated or fraudulent, posing significant risks to investor funds. Until verifiable evidence of legitimate authorization is provided, we assess Ambrielle Novairex as a likely unlicensed broker and advise extreme caution.
Ambrielle Novairex’s website provides no regulatory disclosures and fails to list basic corporate information, such as its legal entity name, registered address, jurisdiction of incorporation, or contact details. This lack of transparency makes it impossible to verify whether the platform holds any valid license or operates under legitimate oversight.
Platforms with these characteristics are often unregulated or fraudulent, posing significant risks to investor funds. Until verifiable evidence of legitimate authorization is provided, we assess Ambrielle Novairex as a likely unlicensed broker and advise extreme caution.
- 2026-09-09 The ASIC issues a warning against Ambrielle Novairex
On Sep 10, 2026, the Australian Securities & Investments Commission(ASIC) issued a warning against Ambrielle Novairex, believing this company might be providing financial services or products without proper authorization in Australia. You may visit: https://www.amf-france.org/en/warnings/blacklists/crypto-currencies/ambrielle-novairex-frcom
On Sep 10, 2026, the Australian Securities & Investments Commission(ASIC) issued a warning against Ambrielle Novairex, believing this company might be providing financial services or products without proper authorization in Australia. You may visit: https://www.amf-france.org/en/warnings/blacklists/crypto-currencies/ambrielle-novairex-frcom
comments
Be the first to review.
Rate and Review
Copyright © 2026 FastBull Ltd
Risk Warning
FX trading is of high risk and may not be suitable for all investors. Leverage will create additional risks and loss. Before trading, please carefully consider your investment objectives, experience level and risk tolerance. You may lose part or all of your initial investment; do not invest money that you cannot afford. Educate yourself about the risks associated with FX trading. If you have any questions, please consult an independent financial or tax advisor. Any data and information are provided "as is" and only for information purpose, not for trading or recommendations. Past performance does not predict future results.
Disclaimer
The data contained in this website may not be real-time and accurate. The data and prices on this site are not necessarily provided by the market or exchange, but may be provided by market makers, so prices may be inaccurate and differ from actual market prices. Namely, this price is indicative price only to reflect market trend, and is unfavorable for trading purpose. The provider of the data contained in the Website shall not be liable for any loss incurred by you as a result of your trading activities or reliance on the information contained in the Website.